1 / 7

Pharmacovigilance and Drug Safety Software Market Global Forecast to 2019

The report “Pharmacovigilance and Drug Safety Software Market by Functionality (Adverse Event Reporting, Fully Integrated Software), Delivery Mode (On-premise, On-demand/Cloud based (SAAS)), End-user (Pharma & Biotech Companies, CROs, BPOs) - Global Forecast to 2019” analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).

poonam26
Download Presentation

Pharmacovigilance and Drug Safety Software Market Global Forecast to 2019

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. MarketsandMarkets Presents Pharmacovigilance and Drug Safety Software Market Global Forecast to 2019 http://http://www.marketsandmarkets.com/Market-Reports/drug-safety-pharmacovigilance-software-market-16831714.html

  2. The report “Pharmacovigilance and Drug Safety Software Market” by Functionality (Adverse Event Reporting, Fully Integrated Software), Delivery Mode (On-premise, On-demand/Cloud based (SAAS)), End-user (Pharma & Biotech Companies, CROs, BPOs) - Global Forecast to 2019” analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the world (RoW). Browse 74 market data tables and 57 figures spread through 210 pages and in-depth TOC on “Pharmacovigilance and Drug Safety Software Market” Get Discount http://www.marketsandmarkets.com/discountreports.asp?id=16831714 The global pharmacovigilance and drug safety software market is poised to grow at a CAGR of 6.5% during 2014-2019, and is expected to reach a value of $154.1 Million in 2019. http://www.marketsandmarkets.com/Market-Reports/drug-safety-pharmacovigilance-software-market-16831714.html pment-ma

  3. On the basis of functionality, the global pharmacovigilance software market is classified into four major segments, namely, adverse event reporting software, drug safety audits software, issue tracking software, and fully integrated software. Download PDF Broacher : http://www.marketsandmarkets.com/pdfdownload.asp?id=16831714 On the basis of functionality, the global pharmacovigilance software market is classified into four major segments, namely, adverse event reporting software, drug safety audits software, issue tracking software, and fully integrated software. The global drug safety software market is divided into two segments on the basis of delivery mode, namely, on-premise delivery mode and on-demand/cloud based (SaaS) delivery mode. This market is also divided into pharma and biotech companies, contract research organizations (CROs), business process outsourcing (BPO) firms, and other pharmacovigilance service providers on the basis of type of end user. http://www.marketsandmarkets.com/Market-Reports/drug-safety-pharmacovigilance-software-market-16831714.html

  4. The global pharmacovigilance software market is expected to grow at a CAGR of 6.5% from 2014 to 2019. Factors such as increasing incidence rates of adverse drug reactions (ADRs) and growing adoption of pharmacovigilance software by organizations such as CROs and BPOs are driving the growth of the global pharmacovigilance software market. In addition; government regulatory bodies (such as the U.S. FDA and EMEA) have intensified safety regulations for prior and post commercialization of drugs, which has increased pressure on the pharmaceutical and biotechnology companies to manufacture safe drugs and evaluate their results post sales. Thus, growing complexity related to drug safety regulations is expected to drive the growth of the market during the forecast period. New service launches; agreements, and partnerships; software developments; and geographical expansions are some of the key strategies adopted by most of the market players to achieve growth in the pharmacovigilance software market. http://www.marketsandmarkets.com/Market-Reports/drug-safety-pharmacovigilance-software-market-16831714.html

  5. North America is expected to account for the largest share of the drug safety software market, followed by Europe, in 2014. However, Asian and Latin American countries represent high growth markets, owing to a rise in research outsourcing by pharmaceutical giants and growing public and private investments in pharmaceutical R&D in these emerging nations. Some of the key players in the global pharmacovigilance software market include ArisGlobal (U.S.), Ennov Solutions Inc. (U.S.), EXTEDO GmbH (U.S.), Online Business Applications, Inc. (U.S.), Oracle Corporation (U.S.), Sarjen Systems Pvt. Ltd (India), Sparta Systems, Inc. (U.S.), and United BioSource Corporation (U.S.), among others. ArisGlobal (U.S.), Ennov Solutions Inc. (U.S.), EXTEDO GmbH (U.S.), Online Business Applications, Inc. (U.S.), Oracle Corporation (U.S.), Sarjen Systems Pvt. Ltd (India), Sparta Systems, Inc. (U.S.), and United BioSource Corporation (U.S.) are some of the key players operating in the global drug safety software market. http://www.marketsandmarkets.com/Market-Reports/drug-safety-pharmacovigilance-software-market-16831714.html

  6. About MarketsandMarkets™ MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.  http://www.marketsandmarkets.com/Market-Reports/drug-safety-pharmacovigilance-software-market-16831714.html

  7. Contact Us Mr. Rohan MarketsandMarkets™ 701 Pike Street Suite 2175, Seattle, WA 98101, United States Tel: 1-888-600-6441 Email: sales@marketsandmarkets.comMarketsandMarkets Bloghttp://www.marketsandmarkets.comhttp://twitter.com/marketsmarkets http://www.linkedin.com/company/marketsandmarkets

More Related